Sansure Biotech Inc.’s Net Profit Dropped 13.6% in 2022

Sansure Biotech Inc. (圣湘生物科技股份有限公司) (688289.SH) reported a net profit of 1.9 billion yuan in 2022, down 13.6% year-on-year.

Meanwhile, the company posted 6.5 billion yuan in revenue, up 42.9% year-on-year.

At the end of the reporting period, it had 9.2 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 18.1%.

This article was automatically produced by Caixin Automation on April 27, 2023.

Download our app to receive breaking news alerts and read the news on the go.